The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

3 Feb 2015 07:00

RNS Number : 8398D
Immunodiagnostic Systems Hldgs PLC
03 February 2015
 



 

 

RNS Announcement

3 February 2015

 

Immunodiagnostic Systems Holdings plc

Patricio Lacalle Appointed New Chief Executive Officer

Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets quoted on AIM, today announces that Patricio Lacalle has been appointed Chief Executive Officer and will join IDS as a Director effective 1 April 2015.

Patricio is currently the CEO of Pulsion Medical Systems SE, a medical technology company with a leading market position in hemodynamic monitoring. In the four years which he has spent at Pulsion Patricio and his team were able to lead the company to international growth while significantly expanding the operating margin. Before Pulsion Patricio held a number of management positions at Forbo Adhesives and HB Fuller.

On 1 April 2015, Burkhard Wittek, Executive Chairman, will revert to being Non-Executive Chairman.

Dr Burkhard Wittek, Executive Chairman of Immunodiagnostic Systems, said "IDS is delighted to announce the appointment of Patricio as Chief Executive Officer. We have worked together at Pulsion and were able to build a company setting standards of business quality in its field. Patricio brings to IDS a strong business sense, a bias for action and great team building and leadership skills. Our leadership team at IDS is looking forward to working with Patricio and together achieving our ambitions for driving growth and profitability."

The following disclosures are made in accordance with AIM rule 17 and Schedule 2 paragraph (g) of the AIM Rules:

Carlos Patricio Lacalle Zando, aged 49 is currently a director of Pulsion Medical Systems SE, Germany, Pulsion Medical UK Ltd., Pulsion France S.A.R.L., Pulsion Austria GmbH, Pulsion Medical Inc., USA, Pulsion Benelux N.V., Belgium, Pulsion Pacific PTY., Australia, Pulsion Switzerland GmbH, Pulsion Poland Sp.z.o.o., Pulsion Iberica S.L, Spain, Pulsion Medical Systems S. de RL de CV, Mexico, Pulsion Medical Systems Medikal Ürünler Ticaret Limited Sirketi, Turkey and in the previous five years he has also been a director of Forbo Adhesives Deutschland GmbH and Forbo Adhesives Schweiz AG.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUQAPUPAPUP
Date   Source Headline
28th Jun 201612:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20161:42 pmRNSDirector/PDMR Shareholding
22nd Jun 20167:45 amRNSAnnual Report and Accounts
22nd Jun 20167:00 amRNSPreliminary Results
9th Jun 20167:00 amRNSUpdate re Royalty Revenues
20th May 20169:20 amRNSHolding(s) in Company
6th May 201610:30 amRNSLaunch of IDS-iSYS 17-OH Progesterone assay
25th Apr 20167:00 amRNSFull Year Trading Update
8th Jan 20167:00 amRNSRelocation of Automated related Assay Activity
4th Jan 20167:30 amRNSPaul Martin joins as Group Finance Director
18th Dec 20159:43 amRNSLaunch of Salivary Cortisol Hypertension Assay
30th Nov 201510:41 amRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report
22nd Oct 20152:22 pmRNSDirectorate Change
21st Oct 20155:00 pmRNSHolding(s) in Company - Replacement
20th Oct 20152:23 pmRNSDirectorate Change
13th Oct 20157:00 amRNSTrading Statement
8th Oct 20154:40 pmRNSHolding(s) in Company
1st Oct 201512:05 pmRNSTotal Voting Rights
30th Sep 20152:05 pmRNSHolding(s) in Company
15th Sep 20154:32 pmRNSAdditional Listing
4th Aug 20152:43 pmRNSResult of AGM
4th Aug 20157:00 amRNSAGM Statement
29th Jun 20153:18 pmRNSRe Report and Accounts and AGM - Replacement
29th Jun 201511:59 amRNSRe Report and Accounts and AGM
29th Jun 20157:15 amRNSDirectorate Change
23rd Jun 20157:00 amRNSFinal Results
12th Jun 20154:00 pmRNSBoard Appointment
10th Jun 20157:00 amRNSDirectorate Change
29th May 20157:00 amRNSTrading Statement
21st Apr 20157:00 amRNSTrading Statement
2nd Apr 20157:43 amRNSPatricio Lacalle Joins as Chief Executive Officer
9th Feb 201510:30 amRNSHolding(s) in Company
3rd Feb 20157:00 amRNSDirectorate Change
6th Jan 20155:04 pmRNSAdditional Listing
5th Jan 20155:10 pmRNSAdditional Listing
24th Dec 20141:30 pmRNSDirectorate Change
19th Dec 201410:47 amRNSHolding(s) in Company
19th Dec 20148:40 amRNSHolding(s) in Company
18th Dec 20149:30 amRNSDirector/PDMR Shareholding
15th Dec 20145:13 pmRNSHolding(s) in Company
12th Dec 20147:00 amRNSLaunch of 1,25-Dihydroxy Vitamin D Assay
8th Dec 20143:38 pmRNSHolding(s) in Company
4th Dec 20145:36 pmRNSDirectorate Change
4th Dec 20144:27 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSDirectorate Change
25th Nov 20147:00 amRNSHalf Yearly Report
24th Nov 20145:20 pmRNSPatrik Dahlen Resigns as CEO
14th Oct 20147:00 amRNSTrading Update
15th Sep 20147:00 amRNSUpdate on current trading

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.